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The major physiological stimuli of aldosterone secretion are angiotensin II (AII) and extra-
cellular K+, whereas cortisol production is primarily regulated by corticotropin (ACTH) 
in fasciculata cells. AII triggers Ca2+ release from internal stores that is followed by 
store-operated and voltage-dependent Ca2+ entry, whereas K+-evoked depolarization 
activates voltage-dependent Ca2+ channels. ACTH acts primarily through the formation 
of cAMP and subsequent protein phosphorylation by protein kinase A. Both Ca2+ and 
cAMP facilitate the transfer of cholesterol to mitochondrial inner membrane. The cytosolic 
Ca2+ signal is transferred into the mitochondrial matrix and enhances pyridine nucleotide 
reduction. Increased formation of NADH results in increased ATP production, whereas 
that of NADPH supports steroid production. In reality, the control of adrenocortical func-
tion is a lot more sophisticated with second messengers crosstalking and mutually mod-
ifying each other’s pathways. Cytosolic Ca2+ and cGMP are both capable of modifying 
cAMP metabolism, while cAMP may enhance Ca2+ release and voltage-activated Ca2+ 
channel activity. Besides, mitochondrial Ca2+ signal brings about cAMP formation within 
the organelle and this further enhances aldosterone production. Maintained aldosterone 
and cortisol secretion are optimized by the concurrent actions of Ca2+ and cAMP, as 
exemplified by the apparent synergism of Ca2+ influx (inducing cAMP formation) and 
Ca2+ release during response to AII. Thus, cross-actions of parallel signal transducing 
pathways are not mere intracellular curiosities but rather substantial phenomena, which 
fine-tune the biological response. Our review focuses on these functionally relevant 
interactions between the Ca2+ and the cyclic nucleotide signal transducing pathways 
hitherto described in the adrenal cortex.
Keywords: cAMP, Ca2+ signal, mitochondria, aldosterone, angiotensin ii, ACTH, potassium ion, cortisol
inTRODUCTiOn
The adrenal cortex contains three zones, of which glomerulosa secretes the mineralocorticoid aldos-
terone, fasciculata synthesizes the glucocorticoid cortisol (or corticosterone in rodents), whereas 
the reticularis produces androgens [reviewed in Ref. (1)]. Aldosterone, acting on the distal nephron, 
augments Na+ reabsorption as well as K+ and H+ excretion. Through changes in sodium balance, 
it influences the extracellular fluid space and blood pressure, and its importance in cardiovascular, 
renal, and inflammatory diseases has also been recognized (2–4). Cortisol, among other things, 
controls intermediary metabolism, modulates immune responses, and is essential for the resistance 
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of the organism to noxious stimuli. Adrenal androgens exert 
important anabolic effects in females and have substantial clinical 
significance in adrenal pathologies.
Sodium and/or fluid depletion, hemodynamic changes, 
and hyperkalemia stimulate aldosterone secretion. When 
fluid loss is severe, ACTH synergizes with angiotensin II 
(AII) in stimulating glomerulosa cells. During hypervolemia, 
atrial natriuretic peptide (ANP) inhibits aldosterone secre-
tion [for reviews, see Ref. (5, 6)]. Cortisol production is 
governed by ACTH. The regulation of ACTH secretion and 
the signaling in zona reticularis (7) are beyond the scope of 
this review.
CLASSiCAL SiGnALinG PATHwAYS in 
THe ADRenAL CORTeX
Signaling Pathways in Glomerulosa Cells
The major signaling pathways of ACTH, K+, and AII, termed 
“classical” here have been described in several reviews [e.g., Ref. 
(5, 6, 8, 9)] and are only briefly summarized below.
ACTH binds to the melanocortin-type receptor MC2R, which 
activates adenylyl cyclase (AC) via the heterotrimeric G-protein 
Gs (10, 11), and subsequent cAMP formation activates protein 
kinase A (PKA). PKA then phosphorylates and induces the hor-
mone-sensitive lipase (previously “cholesterol ester hydrolase”) 
(12) as well as the steroidogenic acute regulatory protein (StAR), 
the protein transporting cholesterol into the mitochondria (13, 
14). As a result of these, the steroid precursor cholesterol is 
released from lipid droplets and transported to side-chain cleav-
age by CYP11A1, located in the inner mitochondrial membrane. 
This causes the stimulation of adrenal steroidogenesis.
Extracellular K+ and AII act by generating cytosolic Ca2+ 
signal. Depolarization induced by physiological elevations of [K+] 
activates T-type voltage-dependent Ca2+ channels the current of 
which was detected in rat (15–17), bovine (16, 18, 19), and human 
glomerulosa cells (20). Concomitant cell swelling evoked by K+ 
also enhances this T-type current (21, 22).
The unique sensitivity of glomerulosa cells to K+ (6, 23, 24) 
may be attributed to their high permeability to K+ (19, 25–28) and 
the function of the T-type channel Cav3.2. The channel’s subunit 
α1H is expressed in rat, murine, and bovine glomerulosa cell (29, 
30). In view of the very negative membrane potential of isolated 
glomerulosa cells (27, 31), basal Ca2+ influx was attributed to a 
steady-state window current (19, 32). The control of Cav3.2 in 
glomerulosa cells has recently been analyzed in murine adrenal 
slices (30), in which cells had a mean resting potential of −82 mV. 
Spontaneous membrane potential oscillations generated by 
Cav3.2 were observed between −87 and −75 mV. Increasing [K+] 
up to 5 mM depolarized the membrane and increased oscillation 
frequency and peak amplitudes, whereas the increased frequency 
upon AII stimulation was most probably due to a Gi-mediated 
shift in the voltage dependence of channel activation toward 
more negative potentials (33). In either cases, the ensuing Ca2+ 
signal (via CaMKII and p42/44 MAP kinase) acts on hormone-
sensitive lipase (34) and StAR (13, 35, 36) [similarly to the actions 
of PKA (37)].
Angiotensin II stimulates aldosterone secretion after binding 
to AT1 receptors (AT1Rs) (38–40). Acting via the G-protein 
Gq and phospholipase Cβ, it induces the formation of inositol 
1,4,5- trisphosphate (IP3) (41–43) which, through specific 
 receptors [IP3Rs (44–46)] generates Ca2+ signal. Out of the three 
receptor isoforms expressed in glomerulosa cells (47), the domi-
nant IP3R1 exhibits the greatest affinity for IP3. The initial Ca2+ 
release is followed by Ca2+ influx (48, 49) through store-operated 
(50, 51) and later via T-type Ca2+ channels (18, 33) [but see 
Ref. (52)]. In isolated rat glomerulosa cells, AII-induced T-type 
current is activated by depolarization (19) brought about by the 
inhibition of the Na+/K+ pump (53) and by the two-pore domain 
K+ channel TASK (25, 54). In murine cells maintained in  situ, 
T-current is enhanced by a Gi-mediated increase in the frequency 
of oscillating action potentials (30, 33).
Angiotensin II inhibits L-type current (55) and thus attenuates 
Ca2+ signals evoked by high [K+] (56, 57). This effect of the pep-
tide is mediated by the G-protein Gi, expressed in glomerulosa 
cells (55, 58).
Due to space limits, this review does not deal with diacyl-
glycerol  –  protein kinase C (PKC), lipoxygenase, and MAPK 
pathways [reviewed, e.g., in Ref. (6)].
Signaling in Fasciculata Cells
The physiological stimulus of glucocorticoid synthesis and secre-
tion by fasciculata cells is ACTH, acting via MC2R receptors and 
cAMP. The mode of cAMP action is identical to that described 
above for glomerulosa cell [for review, see Ref. (59)].
ACTH action on fasciculata cells requires Ca2+. As observed 
already in the 70s, ACTH induces membrane potential changes 
(60) due mainly to Ca2+ influx (61). Both T-type (Cav3.2) and 
L-type (Cav1.3 and a non-identified) isoforms were characterized 
in bovine fasciculata cells, and their participation in ACTH- and 
AII-stimulated cortisol secretion was demonstrated (62). We 
are not aware of data on Ca2+ channels in rat and native human 
fasciculata cells; however, the observation that rat fasciculata 
cells were unresponsive to 13 mM K+ (23) indicates the lack of 
T-type Ca2+ channels. The resting membrane potential in bovine 
fasciculata cells is set by the background K+ channel bTREK-1 
(63), whereas the TASK-3 background K+ channel, characteristic 
for rat glomerulosa cell (26), is undetectable in bovine fasciculata 
cells (64).
Albeit AT1R is expressed in human, bovine, and ovine fas-
ciculata cells (65–67) data whether AII alone stimulates cortisol 
secretion are conflicting (62, 68–70). Rat fasciculata cells do not 
express detectable amounts of AT1R (71–73) [but see Ref. (74)] 
or inositol 1,4,5-trisphosphate receptor (IP3R) mRNA (47) and, 
accordingly, AII does not stimulate steroid production in these 
cells (23, 74, 75).
The expression of AT1R in fasciculata cells and the stimulation 
of cortisol secretion by the peptide raise the question whether 
AII plays any role in the control of cortisol secretion in man. 
In lack of comprehensive studies, we hypothesize that in stress 
situations, stimulation of fasciculata cells by AII may contribute 
to the stimulatory action of ACTH. On the other hand, in case 
of long-term high AII levels, cortisol secretion is maintained at 
resting level by the feed-back control of ACTH secretion.
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The human adrenocortical cancer-derived H295R cell, a widely 
used model for studying steroid production, does not express 
either MC2R receptors (76) or Cav3.2 T-type Ca2+ channels (30) 
[but see Ref. (77)]. Not surprisingly, these cells are insensitive to 
ACTH and respond to K+ at supraphysiological concentrations 
only (78).
inTeRACTiOn OF SiGnALinG 
PATHwAYS in ADRenOCORTiCAL 
CeLLS
(Auto)Regulation of Ca2+ Metabolism 
by Ca2+
The formation, metabolism, and the action of IP3 all depend on 
cytosolic [Ca2+] ([Ca2+]c). Phospholipase Cγ, generating IP3 from 
PIP2 (79) and the IP3 metabolizing IP3-3 kinase are both activated 
by Ca2+ (80–82). High [Ca2+]c may reduce IP3 binding (83), 
whereas elevation of [Ca2+]c up to ~300 nM increases the sensitiv-
ity of IP3R1 to IP3 [reviewed in Ref. (6)]. These characteristics 
play an important role in the oscillatory pattern of Ca2+ release. 
IP3R phosphorylation by PKA, PKC, or CaMKII enhances Ca2+ 
release, while calcineurin decreases this phosphorylation state 
(84). Also, calcium–calmodulin activates the plasmalemmal Ca 
ATPase (85) and inhibits the Na+/K+ ATPase (86, 87), the latter 
resulting in depolarization and Ca2+ influx through T-type chan-
nels (see Signaling Pathways in Glomerulosa Cells).
effects of Ca2+ on Cytosolic cAMP
Early reports on K+-evoked cAMP formation suggested a role for 
Ca2+ in the activation of AC (88, 89). Maintained secretagogue 
effect of ACTH in rat glomerulosa (90) and bovine fasciculata 
cells is also Ca2+-dependent (62) with calcium–calmodulin affect-
ing primarily the formation of cAMP (91). In fact, in bovine cells, 
the effect of ACTH on cAMP formation correlates to extracellular 
[Ca2+] (92), and ACTH-induced cAMP formation is potentiated 
by AII in the presence of Ca2+ only (69).
Nevertheless, conflicting data were reported concerning 
the effect of AII on cAMP formation in bovine adrenocortical 
cells (69, 93–95). Reduced cAMP formation was reported in 
AII-stimulated rat glomerulosa cells (96, 97), whereas enhanced 
cAMP formation was observed in the human H295R cell (98). 
In this respect, the Ca2+ sensitivity of different transmembrane 
adenylyl cyclase isoforms (99, 100) should be considered. The 
Ca2+-activatable isoform AC1 is expressed in human glomerulosa 
and fasciculata cells (99); the Ca2+/calmodulin-activatable AC3 
was found in human (99), rat (101), and bovine (69) glomerulosa 
cells. Ca2+-inhibited isoforms (AC5 and AC6) were detected in 
human (99) and rat glomerulosa cells (102). It should also be kept 
in mind that Ca2+-activatable AC isoforms are more responsive to 
store-operated Ca2+ entry than to Ca2+ release. This phenomenon 
is due to the colocalization of Ca2+ activatable AC isoforms and 
store-operated Ca2+ channels in plasmalemmal lipid rafts (103) 
and may account for the delayed cAMP response to AII (98).
After the description of Gi in rat glomerulosa cells (58), the 
reported inhibition of AC by AII was attributed to this inhibitory 
G-protein (55, 95). Summarizing, the cell-type differences in the 
effect AII on AC may be attributed to Gi density and the ratio of 
the various AC isoforms.
The Ca2+-modified signaling pathways are summarized in 
Figure 1.
effects of cAMP on Ca2+ Signaling
ACTH or cell-permeable cAMP analogs may induce a sustained 
Ca2+ signal after a lag time of a few minutes as was shown in 
rat (104), bovine (92), and human glomerulosa cells (105), as 
well as in H295R cells (106). Several molecular interactions may 
warrant such an effect. PKA phosphorylates L-type Ca2+ chan-
nels (105, 107) [but see Ref. (108)], the ensuing Ca2+ current 
activates phospholipase Cδ, and the generated IP3 induces Ca2+ 
release from the endoplasmic reticulum (ER). In addition, PKA 
also phosphorylates and activates IP3R1 [reviewed in Ref. (6)]. In 
fact, ACTH evokes a small phosphoinositide response (109) and 
PKC activation (110) in rat glomerulosa cells. By the same token, 
8Br-cAMP enhanced AII-induced IP3 formation in bovine cells 
(111). Taken together, cAMP and its downstream effectors may 
enhance both Ca2+ influx and Ca2+ release in the adrenals.
The cAMP-modified signaling pathways are summarized in 
Figure 2.
Signaling Modulation by cGMP
Cyclic GMP is formed after the activation of ANP receptors. The 
nucleotide reduces T-type Ca2+ current (112) and inhibits the 
AC (113). In addition, cGMP activates PDE2A (114–116), one 
of phosphodiesterase isozymes identified in adrenocortical cells 
[reviewed by Vezzosi and Bertherat (117)]. By these actions, ANP 
reduces basal and stimulated aldosterone secretion (112).
Synergistic effects of Ca2+ Release and 
Ca2+ influx
Moderate hyperkalemia increases the sensitivity and the maximal 
aldosterone response to AII (118–120). Potassium (4–8  mM) 
potentiates the secretory response to thapsigargin (evoking net 
Ca2+ release from the ER), whereas the secretory effects of thapsi-
gargin and AII (300 pM) are additive only (119). When net Ca2+ 
release was induced with Ni2+, an inhibitor of microsomal Ca2+ 
uptake, the aldosterone response to physiological concentrations 
of K+ was again potentiated (121). These observations indicate that 
Ca2+ release and influx act in synergism on aldosterone secretion.
The synergism between Ca2+ release and influx may be explained 
by the formation of microdomains. Increased subplasmalemmal 
[Ca2+] (formed around the orifice of Ca2+ channels) may activate 
e.g., Ca2+-dependent AC isoforms and may induce specific gene 
expression (122, 123). On the other hand, Ca2+ release into the 
perinuclear space may turn on Ca2+-dependent nuclear genes and 
enhance NAD(P)H formation in ER-vicinal mitochondria (see 
Ca2+ Signal and Mitochondrial Function). In addition, the reduc-
tion in exchangeable Ca2+ pool during exposure to AII (124) may 
be counterbalanced by concomitant Ca2+ influx.
Angiotensin II-induced initial IP3 peak is followed by sus-
tained suprabasal IP3 formation (41). Li+ inhibits the resynthesis 
of phosphoinositides and precludes the maintained formation 
of IP3, and thus attenuates the post-initial phase of AII-induced 
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(but not ACTH-induced) aldosterone output of glomerulosa cells 
(125). This indicates that sustained suprabasal IP3 formation, Ca2+ 
release and, probably, store-operated Ca2+ entry all support long-
lasting aldosterone secretion.
eFFeCTS OF COnveRGenT SiGnALinG 
On Gene eXPReSSiOn
Both Ca2+ and cyclic nucleotide signaling affect the transcrip-
tome of adrenocortical cells (126, 127). Complex transcriptional 
or epigenetic (128) changes during adrenal zonation, remod-
eling, and neoplastic transformation are beyond the scope 
of this study [for review, see, e.g., Ref. (129, 130)]. Instead, 
we focus on instances where gene expression is modulated by 
parallel signal transducing pathways. One illustrative example 
of such an interplay involves the transcriptional regulation of 
hormone-sensitive lipase and StAR, both of which are induced 
by the cAMP-PKA (12–14) and by the Ca2+ pathway (13, 34–36). 
Along similar lines, Ca2+ and cAMP, through overlapping cis 
regulatory elements, synergistically induce the transcription 
of aldosterone synthase (CYP11B2) (131) and (as observed in 
non-adrenal cells) the mitochondrial Ca2+ uniporter (MCU, see 
below) (132). Transcription of type I 3β-hydroxysteroid dehydro-
genase (HSD3B1), expressed predominantly in the human zona 
glomerulosa (133), can be induced by AII but not by K+ (134). 
A plausible explanation is that only AII [in part via PKC (135, 
136)] recruits the nuclear receptor subfamily 4 (NGFI-B), which 
is also necessary for the induction of HSD3B1. In contrast, both 
AII and K+ induce CYP11B2 expression via the Ca2+/CaMK and 
MAP kinase pathways (137).
In vascular smooth muscle cells, both Gs- and Gq-initiated 
signaling dampen the expression of AT1R through mRNA desta-
bilization (138). Interestingly, to carry out this mRNA degrada-
tion, the pathways partially converge on PKA (139). An effect 
closely reminiscent of such a convergence was observed in H295R 
cells where forskolin, db-cAMP, and AII all brought about a rapid 
drop in AT1R message levels. [Nevertheless, long-term AT1R 
repression was induced with forskolin/db-cAMP only (140).]
Ca2+ SiGnAL AnD MiTOCHOnDRiAL 
FUnCTiOn
Calcium activates three dehydrogenases in suspended or homog-
enized mitochondria (141). Ca2+-dependent mitochondrial 
NADH and NADPH (NAD(P)H) formation in living cells was 
first demonstrated in K+-stimulated glomerulosa cells (142). 
Similar response to AII and vasopressin was also reported (143, 
144). The significance of increased NADH and ensuing ATP 
production (145) in any biological response is obvious, whereas 
NADPH is a cofactor of steroid biosynthesis (1). Noteworthy, the 
spatial and temporal pattern of AII-induced cytosolic Ca2+ signal 
depends on mitochondrial metabolism (78).
FiGURe 1 | effects of Ca2+ on cytosolic cAMP in glomerulosa cells. Positive modulations are shown with green arrows and negative effects are shown with 
red blunted arrows. Black arrows indicate substance transport. Cav1.3, L-type voltage-dependent Ca2+ channel; Cav3.2, T-type voltage-dependent Ca2+ channel; 
ANP, atrial natriuretic peptide; AII, angiotensin II; AT1R, angiotensin II receptor type 1, Gi and Gq, heterotrimeric G-proteins; PIP2, phosphatidyl inositol 
1,4,5-trisphosphate; TASK, KCNK3 or KCNK9-type K+ channel; AC, transmembrane adenylyl cyclase; ER, endoplasmic reticulum; IP3, inositol 1,4,5-trisphosphate; 
IP3R, IP3 receptor; HSL, hormone-sensitive lipase; StAR, steroidogenic acute regulatory protein.
FiGURe 2 | effects of cAMP on Ca2+ signaling in glomerulosa cells. Positive modulations are shown with green arrows and negative effects are shown with 
red blunted arrows. Black arrows indicate substance transport. Cav1.3, L-type voltage-dependent Ca2+ channel; Cav3.2, T-type voltage-dependent Ca2+ channel; 
ANP, atrial natriuretic peptide; AII, angiotensin II; AT1R, angiotensin II receptor type 1, Gi and Gq, heterotrimeric G-proteins; AC, transmembrane adenylyl cyclase; 
ER, endoplasmic reticulum; IP3R, IP3 receptor; HSL, hormone-sensitive lipase; StAR, steroidogenic acute regulatory protein; ACTH, corticotropin; MC2R, 
melanocortin receptor type 2, PDE, cAMP phosphodiesterase; AMP, adenosine monophosphate.
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The primary event in the mitochondrial response to a cytosolic 
Ca2+ signal is the transfer of the ion into the mitochondrial matrix 
(146–149). Ca2+ transport occurs through the MCU complex, 
the velocity of which is a sigmoid function of [Ca2+]c due to the 
allosteric control of the MCU channel by the regulatory subu-
nits MICU1 and MICU2 [reviewed in Ref. (150)]. IP3-induced 
Ca2+ release from the ER generates high-Ca2+ microdomains 
between the ER and mitochondria and allows for mitochondrial 
Ca2+ uptake by the low-Ca2+-affinity MCU (151). However, the 
mitochondria of glomerulosa cells are uniquely sensitive to Ca2+ 
(152) and influx-induced low-Ca2+ signals are also effective in 
elevating mitochondrial [Ca2+] ([Ca2+]m) (153). This responsive-
ness may be essential for maintained aldosterone secretion in 
response to long-lasting hyperkalemia, characterized by small 
elevation of [Ca2+]c.
Increased [Ca2+]m and the ensuing NAD(P)H formation play 
an essential role in the stimulation of aldosterone production. 
Targeted mitochondrial expression of a Ca2+ binding protein 
reduces both [Ca2+]m and NAD(P)H and ensuing aldosterone 
production in response to AII (154). The opposite, increased 
mitochondrial Ca2+ uptake after the knockdown of p38 MAPK 
or the silencing of mitochondrial protein OPA1 results in 
increased NAD(P)H formation and enhanced aldosterone 
production (155).
A recently recognized and biologically significant action of 
Ca2+ signaling is the formation of cAMP in mitochondria. In 
addition to the nine isoforms of transmembrane AC, a soluble 
isoform (sAC) was prepared from testis (156). Its activity is not 
influenced by forskolin or G-proteins but increased by bicarbonate 
(157) and Ca2+ (158). The expression of sAC in the mitochondrial 
matrix together with a degrading mechanism sensitive to phos-
phodiesterase 2A inhibitors were recently described in HeLa cells 
(159, 160). The activity of intramitochondrial sAC increased in 
response to mitochondrial Ca2+ signal in HeLa and CHO cells 
and in rat cardiomyocytes (161). Importantly, mitochondrial 
cAMP (mt-cAMP) supported ATP formation (160, 161).
The sAC is also expressed in H295R adrenocortical cells, and it 
is found in the particulate fraction predominantly. In these cells, 
AII-induced mitochondrial Ca2+ signal increased the formation 
of mt-cAMP, and this response was enhanced by the PDE2A 
inhibitor EHNA. Mitochondrial cAMP signaling was attenuated 
with the sAC inhibitor 2-OH-estradiol, after silencing of the sAC 
gene and by the buffering of mitochondrial Ca2+ by S100G pro-
tein. All these maneuvers also attenuated aldosterone production, 
showing the cell-type-specific significance of mt-cAMP for the 
first time (98).
COnCLUSiOn
Adrenocortical steroid production is under the control of both 
Ca2+ signaling and cyclic nucleotide metabolism. Importantly, 
these intracellular pathways are rarely, or probably never, 
independent. As postulated by Berridge in 1975 (162), cAMP 
and Ca2+ signaling may be antagonistic or synergistic in nature 
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